home / stock / xph / xph news


XPH News and Press, SPDR S&P Pharmaceuticals From 02/27/23

Stock Information

Company Name: SPDR S&P Pharmaceuticals
Stock Symbol: XPH
Market: NYSE

Menu

XPH XPH Quote XPH Short XPH News XPH Articles XPH Message Board
Get XPH Alerts

News, Short Squeeze, Breakout and More Instantly...

XPH - Pockets Of Value In Stocks As Rates Rise

Summary We think value stocks can outperform as interest rates head higher. Regions and sectors help us find quality within value and growth at a reasonable price. Stocks slid after the Federal Reserve’s preferred inflation gauge showed persistently high inflation, reinforcing wh...

XPH - Spdr S&p Pharmaceuticals XPH Technical Pivots with Risk Controls

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

XPH - Amphenol Announces First Quarter 2023 Dividend

Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the first quarter 2023 dividend on its Common Stock in the amount of $0.21 per share at its meeting held on February 2, 2023. The Company will pay this first quarter 2023 dividend on April 12, 2023 to shareholde...

XPH - A Stock Picker's Guide To 2023

Summary When I think about the lessons learned from 2022, I think the biggest lesson is valuations matter. I do think this is the most predicted recession that I've ever seen, certainly, in my career. Investors of all stripes, whether you're an asset allocator or a stock picker, I t...

XPH - Amphenol Reports Fourth Quarter and Full Year 2022 Results

Fourth Quarter 2022 Highlights: Sales of $3.239 billion, up 7% in U.S. dollars and 8% organically compared to the fourth quarter of 2021 GAAP Diluted EPS of $0.82, up 14% compared to prior year Adjusted Diluted EPS of $0.78, up 11% compared to prior year GAAP and Adjus...

XPH - Healthy Outlook For Therapeutics

Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...

XPH - More Volatility Ahead? Buckle Up With Defensive Equities

Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...

XPH - Prahlad Singh Appointed to Board of Directors of Amphenol Corporation

Amphenol Corporation (NYSE: APH) today announced that Prahlad Singh, PhD has been appointed to Amphenol’s board of directors. With his appointment, the size of the company’s board has increased to 10 members. Dr. Singh is currently the President and Chief Executive Officer of Pe...

XPH - Healthcare Stocks: An Innovative Antidote For Volatile Times

Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...

XPH - Can Health Care Stocks Outperform Again In 2023?

Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...

Previous 10 Next 10